Skip to content
ClinCalc Pro
Menu
Antihistamine + vitamin B6 (NVP)

Doxylamine with pyridoxine

Brand names: Xonvea

Doxylamine with pyridoxine is a fixed combination of a sedating antihistamine and vitamin B6 used to treat nausea and vomiting of pregnancy.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Doxylamine is an H1-antihistamine with antiemetic and sedative properties, while pyridoxine (vitamin B6) is thought to contribute an additional antiemetic effect; the combination relieves pregnancy-related nausea.

Prescribing in practice

  • Warn that the doxylamine component is sedating and may impair the ability to drive or operate machinery, with additive effects when combined with alcohol or other CNS depressants.
  • It is generally used when conservative measures fail to control nausea and vomiting of pregnancy.
  • Avoid concurrent use with monoamine oxidase inhibitors and use caution in conditions where antimuscarinic effects are problematic, such as narrow-angle glaucoma.

Monitoring

Routine laboratory monitoring is not required; review symptom control and degree of sedation and reassess if vomiting is severe or persistent.

Counselling the patient

  • Drowsiness is common, so avoid driving or operating machinery until you know how it affects you.
  • Avoid alcohol while taking this medicine.
  • Seek urgent review if you cannot keep fluids down or show signs of dehydration.

Evidence & guidelines

A modified-release doxylamine-pyridoxine combination is supported for nausea and vomiting of pregnancy and is reflected in UK guidance on managing this condition.

Reference: RCOG GTG 69; NICE CKS NVP; SmPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.